GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Sale Of Investment

ABL Bio (XKRX:298380) Sale Of Investment : ₩174,824 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Sale Of Investment?

ABL Bio's sale of investment for the three months ended in Mar. 2024 was ₩39,184 Mil. It means ABL Bio gained ₩39,184 Mil from selling investments. ABL Bio's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was ₩174,824 Mil.

Compared with last quarter (₩50,050 Mil in Dec. 2023 ), ABL Bio gained less money from selling investments in Mar. 2024 (₩39,184 Mil).


ABL Bio Sale Of Investment Historical Data

The historical data trend for ABL Bio's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Sale Of Investment Chart

ABL Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial 40,474.08 64,479.48 88,013.97 32,612.07 148,504.48

ABL Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,863.80 30,031.92 55,558.96 50,049.80 39,183.81

ABL Bio Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩174,824 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ABL Bio Sale Of Investment Related Terms

Thank you for viewing the detailed overview of ABL Bio's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


ABL Bio (XKRX:298380) Business Description

Traded in Other Exchanges
N/A
Address
2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488
ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines